CCR7 and B-cell chronic lymphocytic leukemia: Nevertheless, further work on CCR7+ TREG activity in CLL is needed in more samples to shed light on this aspect since patients could benefit from a therapeutic intervention consisting in the depletion of these suppressive cells.